Natural Killer Cell Therapeutics Market Size 2021-26: Global Industry Trends, Share, Growth, Opportunity and Forecast


SHERIDAN, WYOMING, UNITED STATES January 31, 2022 / — According to IMARC Group’s latest report, titled “Natural Killer Cell Therapeutics Market Size: Global Industry Trends, Share, Growth, Opportunities and Forecasts 2021-2026”,

Global Natural Killer Cell Therapeutics Market exhibited strong growth during 2015-2020. Natural killer (NK) cells are large granular lymphocytes responsible for the production of immunoregulatory cytokines. They are a type of white blood cell that function as a vital part of the human immune system. They contain small granules of special proteins like proteases and perforin known as granzymes. NK cell therapeutics are developed by ex vivo preconditioning with cytokines or small molecules drugs and chimeric antigen receptor (CAR) NK. They target pathogen antigens with cytotoxicity and reduce the risk of cytokine storms.

COVID-19 Scenario-

We are constantly tracking and evaluating the impact of the COVID-19 pandemic on the industry. These influences have been treated as significant market contributors in our report.

Request a PDF sample of this report:

The global NK cell therapeutics market is primarily driven by their increasing use in various molecular and combination therapies for various treatments. They are used as effective therapeutics in cancer, liver and infectious diseases. Furthermore, increasing awareness of the importance of immunotherapies has increased the need for better therapeutic options and new product launches, which are expected to impact the market growth in the future. As a result, several research activities have led to the development of allogeneic NK cells with maximum therapeutic effects. They also amplify the target and prolong the persistence of potent immune cells, helping to generate a powerful and sustained immune-mediated attack against cancer. Looking ahead, IMARC Group expects the market to grow at a CAGR of around 15% between 2021 and 2026.

Competitive landscape with key players:
• Affimed GmbH
• Bristol-Myers Squibb Company
• Destiny therapy
• Fortress Biotech Inc.
• Glycostem Therapeutics
• Innate Pharma SA
• Kuur Therapeutics Inc
• Athenex Inc
• Nkarta Inc.
• Takeda Pharmaceutical Company Limited
• Ziopharm Oncology Inc.

Separation by therapeutics:
• NK cell therapies
• Antibodies directed to NK cells

Separation by application:
• Cancer
• Gastrointestinal diseases
• Immunoproliferative diseases
• Other

Separation by end users:
• Hospitals
• Research centers and institutes
• Other

Breakdown by region:
• North America (United States, Canada)
• Europe (Germany, France, UK, Italy, Spain, others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, others)
• Latin America (Brazil, Mexico, others)
• Middle East and Africa (UAE, Saudi Arabia, Qatar, Iraq, others)

Ask the Analyst for Adjustments and Check out the Full Report with TOC and Table of Figures:

We update our reports. If you want the latest primary and secondary data (2021-2026) with cost module, business strategy, sales channel etc. Click “Request Free Sample Report”, the published report will be emailed to you in PDF format within 24 to 48 hours.

Key highlights of the report:
• Market performance (2015-2020)
• Market Outlook (2021-2026)
Market Trends
• Market drivers and success factors
• The impact of COVID-19 on the global market
• Value chain analysis
• Structure of the global market
• Comprehensive mapping of the competitive landscape

If you require specific information that is not currently in the scope of the report, we will provide it as part of the customization.

Related IMARC Group reports:

Market size for prepaid cards in Indonesia:

PVC Pipe Market Size in Europe:

Automotive Connectors Market Report:

Market price trends for awnings:

Medical Simulation Market Report:

about us
IMARC Group is a leading market research company providing management strategies and market research worldwide. We partner with clients across sectors and geographies to identify their most valuable opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products cover key market, scientific, economic and technological developments for executives in pharmaceutical, industrial and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food & beverage, travel & tourism, nanotechnology and advanced processing methods are at the forefront of the company’s expertise.

IMARC Services Private Limited
email us here


Comments are closed.